Moneycontrol
HomeNewsTrendsHealthMaharashtra sees 2,024 COVID-19 cases, 5 deaths; active tally now 11,906

Maharashtra sees 2,024 COVID-19 cases, 5 deaths; active tally now 11,906

Mumbai accounted for 446 of the new coronavirus cases reported during the day

August 05, 2022 / 20:44 IST
Story continues below Advertisement
Representative image

Maharashtra on Friday recorded 2,024 COVID-19 cases and five deaths linked to the infection, which took the tally to 80,55,989 and the toll to 1,48,129, a health department official said. On Thursday, the state recorded 1,862 and seven fatalities.

The five deaths comprised two each in Mumbai and Pune and one in Akola, he said. Mumbai accounted for 446 of the new cases reported during the day, the official said.

Story continues below Advertisement

The recovery count increased by 2,190 in the last 24 hours to touch 78,95,954, leaving the state with an active caseload of 11,906, he said. State health department data showed the fatality rate was 1.83 percent and the recovery rate was 98.01 percent.

The overall number of coronavirus tests conducted in Maharashtra reached 8,33,60,768, including 39,763 in the last 24 hours, as per official data. Maharashtra coronavirus figures are as follows: Total cases 80,55,989; fresh cases 2,024; death toll 1,48,129; recoveries 78,95,954; active cases; 11,960; total tests 8,33,60,768.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show
PTI
first published: Aug 5, 2022 08:44 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!